To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali ...

Supporters will unite on May 5 to mark World Pulmonary Hypertension Day, with a focus this year on early diagnosis.

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

A new study published in The New England Journal of Medicine showed that for high-risk patients with pulmonary arterial ...

A study was conducted to determine the relationship between health care utilization and cardiovascular complication ...

Exclusive e-cigarette use is significantly associated with new cases of chronic obstructive pulmonary disease.

In pulmonary hypertension, a combination of metabolic and mechanical dysfunction leads to irreversible vascular damage.

E-cigarette use is linked to increased risk of COPD and possibly hypertension, though less harmful than traditional smoking, ...

A recent publication by the British Thoracic Society offers the first long-term analysis of the UK Idiopathic Pulmonary ...

Tenax Therapeutics progresses levosimendan for PH-HFpEF with Phase 3 trials, aiming for a first-of-its-kind therapy. Click ...

The study highlighted the significant benefits of long-term oxygen therapy in reducing total and hospitalized acute ...

The new analysis, they note, further verifies that while the use of either e-cigarettes or traditional “combustible” ...